Markus Zojer
Impact in
- Pollution top 10%
- Pharmaceutical and Antibiotic Environmental Impacts
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 2
-
- Epigenetics and DNA Methylation 1
- Co-authors
- Thomas Rattei (4 shared papers)José Luis Martínez (1 shared paper)David Daniel Bogumil (1 shared paper)Itzhak Mizrahi (1 shared paper)Christine Moissl‐Eichinger (1 shared paper)Alexander Mahnert (1 shared paper)Gabriele Berg (1 shared paper)Verena Proell (1 shared paper)
- Journals
- Blood (2 papers)iScience (2 papers)Genome Biology and Evolution (1 paper)Nature Communications (1 paper)Oncotarget (1 paper)
- Partner nations
- AustriaUnited StatesSpain
In The Last Decade
Markus Zojer
15 papers receiving 560 citations
Peers
Comparison fields: 5 of 63
- Applied Microbiology and Biotechnology 14
- Pollution 54
- Hematology 55
- Hepatology 35
- Oncology 88
Countries citing papers authored by Markus Zojer
This map shows the geographic impact of Markus Zojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Zojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Zojer more than expected).
Fields of papers citing papers by Markus Zojer
This network shows the impact of papers produced by Markus Zojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Zojer. The network helps show where Markus Zojer may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Zojer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 182 | |
| 2 | 2019 | 164 | |
| 3 | 2018 | 66 | |
| 4 | 2019 | 39 | |
| 5 | 2019 | 30 | |
| 6 | 2020 | 16 | |
| 7 | 2017 | 15 | |
| 8 | 2018 | 15 | |
| 9 | 2022 | 11 | |
| 10 | 2024 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 7 | |
| 13 | 2025 | 4 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 2 |
About Markus Zojer
Markus Zojer is a scholar working on Hematology, Molecular Biology, Oncology, Molecular Medicine and Genetics, having authored 15 papers that have together received 568 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Cancer-related Molecular Pathways (2 papers), Evolution and Genetic Dynamics (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Epigenetics and DNA Methylation (1 paper) and Insect symbiosis and bacterial influences (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (14 citations), Pollution (54 citations), Hematology (55 citations), Hepatology (35 citations) and Oncology (88 citations). Markus Zojer has collaborated with scholars based in Austria, United States and Spain. Frequent co-authors include Thomas Rattei, José Luis Martínez, David Daniel Bogumil, Itzhak Mizrahi, Christine Moissl‐Eichinger, Alexander Mahnert, Gabriele Berg, Verena Proell, Wolfgang Mikulits and Thomas Waerner. Their work appears in journals such as Blood, iScience, Genome Biology and Evolution, Nature Communications and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.